Molecular Partners AG ADR
Price & Volume
Stats
See more52W Range | $3.53-$5.36 |
Market Cap | $151.3M |
Shares Short | 218 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | -$35.5M |
Diluted EPS | -$1.62 |
News
See moreYahoo Finance • 3 months ago
Molecular Partners Announces Clinical Progress in Phase 2 TACTIC Combination Trial of MP0317 for Patients with Cholangiocarcinoma
Yahoo Finance • 3 months ago
Molecular Partners Showcases Bispecific Radio-DARPins at Gordon Research Conference
Yahoo Finance • 3 months ago
Molecular Partners Updates on Clinical Progress Across Expanding Pipeline of DARPin Radiotherapeutics
Yahoo Finance • 3 months ago
Molecular Partners and Orano Med Announce First Patients Dosed in Phase 1/2a Trial of DLL3 Radio-DARPin MP0712
About
CEO | Dr. Patrick Amstutz Ph.D. |
Address | Wagistrasse 14, Schlieren, Switzerland, 8952 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 134 |